ASH:NYE-Ashland Global Holdings Inc (USD)

COMMON STOCK | Specialty Chemicals |

Last Closing

USD 71.7

Change

+0.29 (+0.41)%

Market Cap

USD 3.56B

Volume

0.14M

Analyst Target

USD 88.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
APD Air Products and Chemicals Inc

+2.47 (+0.84%)

USD 71.19B
PPG PPG Industries Inc

+0.83 (+0.69%)

USD 27.89B
DLY DoubleLine Yield Opportunities..

+0.10 (+0.63%)

USD 27.84B
LYB LyondellBasell Industries NV

+0.11 (+0.15%)

USD 23.87B
ALB Albemarle Corp

+0.79 (+0.89%)

USD 12.34B
AXTA Axalta Coating Systems Ltd

+0.09 (+0.26%)

USD 7.50B
ESI Element Solutions Inc

+0.20 (+0.78%)

USD 6.12B
ALTM Arcadium Lithium plc

+0.29 (+5.84%)

USD 5.22B
AVNT Avient Corp

+0.38 (+0.93%)

USD 4.56B
FUL H B Fuller Company

+0.48 (+0.71%)

USD 4.13B

ETFs Containing ASH

CB1TX:SW Lyxor 1 TecDAX (DR) UCITS.. 12.55 % 0.00 %

N/A

N/A
E908:XETRA Lyxor 1 TecDAX (DR) UCITS.. 12.18 % 0.00 %

N/A

USD 0.09B
EXS2:XETRA iShares TecDAX® UCITS ET.. 12.14 % 0.00 %

N/A

USD 0.77B
EXIB:XETRA iShares TecDAX® UCITS ET.. 12.14 % 0.00 %

N/A

USD 0.77B
TDXPEX:SW iShares TecDAX® UCITS ET.. 12.14 % 0.00 %

N/A

USD 5,933.97B
EGRE:XETRA BNP Paribas Easy ESG Grow.. 7.07 % 0.00 %

N/A

USD 0.07B
EGRO:PA BNP Paribas Easy ESG Grow.. 7.07 % 0.00 %

N/A

N/A
PCIG Litman Gregory Funds Trus.. 6.22 % 0.00 %

+0.05 (+0.54%)

USD 0.03B
EGRA:SW WisdomTree Eurozone Quali.. 4.37 % 0.00 %

N/A

N/A
EMOM:SW 3.59 % 0.00 %

N/A

N/A
IPXE:LSE First Trust IPOX® Europe.. 2.71 % 0.00 %

+0.07 (+0.54%)

N/A
E908:F Lyxor 1 - TecDAX UCITS ET.. 0.00 % 0.00 %

N/A

N/A
EXS2:F iShares TecDAX UCITS ETF .. 0.00 % 0.00 %

N/A

N/A
F751:F 0.00 % 0.00 %

N/A

N/A
F751:XETRA 0.00 % 0.00 %

N/A

N/A
GRNV:AU VanEck MSCI Australian Su.. 0.00 % 0.00 %

+0.12 (+0.54%)

USD 0.17B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.96% 44% F 15% F
Dividend Return 1.90% 59% D- 32% F
Total Return -13.06% 42% F 15% F
Trailing 12 Months  
Capital Gain -15.91% 45% F 14% F
Dividend Return 1.88% 59% D- 32% F
Total Return -14.04% 43% F 14% F
Trailing 5 Years  
Capital Gain -6.77% 41% F 42% F
Dividend Return 9.03% 42% F 27% F
Total Return 2.26% 32% F 29% F
Average Annual (5 Year Horizon)  
Capital Gain 8.32% 43% F 61% D-
Dividend Return 9.76% 45% F 58% F
Total Return 1.43% 47% F 35% F
Risk Return Profile  
Volatility (Standard Deviation) 21.37% 82% B 51% F
Risk Adjusted Return 45.66% 68% D+ 60% D-
Market Capitalization 3.56B 62% D 74% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.